Zhang Y, Meng X, Li A, Xin J, Berman BM, Lao L, Tan M, Ren K, Zhang RX. (2012). Electroacupuncture alleviates affective pain in an inflammatory pain rat model.European Journal of Pain.16(2):170-81.
Voskens CJ, Sewell D, Hertzano R, DeSanto J, Rollins S, Lee M, Taylor R, Wolf J, Suntharalingam M, Gastman BR, Papadimitriou JC, Tan M, Morales R, Cullen K, Celis E, Mann D, Strome SE. (2012). Induction of mage-a3 and hpv-16 immunity by Trojan vaccines in patients with head and neck carcinoma. Head and Neck. DOI: 10.1002/hed.22004.
Liu Z, Bensmail H, Tan M. (2012). Efficient feature selection and multiclass classification with integrated instance and model based learning. Evolutionary Bioinformatics. 8:1-10.
Tkaczuk K, Tait NS, Ioffe OB, Tan M, Goloubeva O, Lesko SA, Deamond S, Zhou D, Lum ZP, Sutula MJ, Van Echo DA, Ts'o PO. (2011). Computer Assisted Quantitative Immunofluorescence of Tumor Tissue Marker Expression and Clinical Outcome to Chemotherapy in Advanced Breast Cancer Patients. Discovery Medicine. 12(68).
Zhang X, Voskens CJ, Sallin M, Maniar A, Montes CL, Zhang Y, Lin W, Li G, Burch E, Tan M, Hertzano R, Chapoval A, Tamada K, Gastman B, Schulze DH, Strome SE (2010). CD137 promotes proliferation and survival of human B cell. J Immunol, 184:(2), 787-95.
Settle K, Posner MR, Schumaker LM, Tan M, Suntharalingam M, Goloubeva O, Strome SE, Haddad RI, Patel SS, Cambell EV III, Sarlis N, Lorch J, Cullen KJ. (2009). Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res, 2:(9), 776-781.
Cullen KJ, Schumaker L, Nikitakis N, Goloubeva O, Tan M, Sarlis NJ, et al. (2009). Beta-tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial. J Clin Oncol, 27:(36), 6222-8.
Liu Z, Gartenhaus RB, Tan M, Jiang F, Jiao X. (2008). Gene and pathway identification with Lp penalized Bayesian logistic regression. BMC Bioinformatics, 9:(1), 412. PMCID: PMC2567351.
Schumaker L, Nikitakis N, Goloubeva O, Tan M, Taylor R, Cullen KJ.(2008). Elevated expression of glutathione S-transferase pi and p53 confers poor prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy alone. Clin Cancer Res, 14:(18), 5877-83.
Liu Z, Jiang F, Tian G-L, Wang S, Sato F, Meltzer SJ, Tan M.(2007). Sparse Logistic Regression with Lp Penalty for Biomarker Identification. Statistical Applications in Genetics and Molecular Biology, 6:(1):Article 6.
Liu Z, Lin S, Tan M. (2006). Genome-wide tagging SNPs with entropy-based Monte Carlo method. J Comput Biol, 13:(9), 606-14.
Tan M, Fang H-B, Tian G-L, Houghton PJ. (2003). Experimental design and sample size determination for testing synergism in drug combination studies based on uniform measures. Stat Med, 22:(13), 2091-100.
Santana VM, Zamboni WC, Kirstein MN, Tan M, Liu T, Gajjar A, et al. (2003). A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumors. Clin Cancer Res, 9:(2), 633-40.
Marshall DR, Turner JT, Belz GT, Wingo S, Andreansky S, Sangster MY, Riberdy JM, Liu T, Tan M, Doherty PC. (2001). Measuring the dispora for virus specific CD8+T cells. Proc Natl Acad Sci USA, 98:(11), 6313-8. PMCID: PMC33465.
Houghton PJ, Stewart CF, Cheshire PJ, Richmond LB, Kirstein MN, Poquette C, Tan M, Friedman HS and Brent TP. (2000) . Antitumor activity of temozolomide combined with irinotecan is partly independent of MGMT and mismatch repair phenotypes in xenograft models.Clin Cancer Res., 6:4110-4118, 2000.
Tan M, Xiong X, Kutner MH. (1998). Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing. Biometrics, 54(2), 682-95.
Tan M, Xiong X. (1996). Continuous and group sequential conditional probability ratio tests for phase II clinical trials. Stat Med, 15:(19) 2037-51.
Qu Y, Tan M, Kutner MH. (1996). Random-effects models in latent class analysis for evaluating accuracy of diagnostic tests. Biometrics, 52, 797-810.